MAPK8 and myocardial infarction: HSP90 elicits immense cardioprotective effect by regulating the complement activation (Wang et al. 2020), JNK signaling (Wang et al. 2020) and eNOS phosphorylation (Kupatt et al. 2004) and has been established as a promising therapeutic target for post-MI management (Wang et al. 2020) (Kupatt et al. 2004).